Tag: Generics

Sandoz Announced Launch of Generic Oncology Medicine Gefitinib in 13 EU Countries

Sandoz
Sandoz announced the launch of the generic oncology medicine gefitinib indicated for adult patients with locally advanced or metastatic non-small cell lung cancer with activating mutations of EGFR-TK,...

Lannett to be Exclusive US Distributor of Dantrolene

Lannett Company, Inc. today announced that it has entered into a three-year agreement with Elite Pharmaceuticals to be the exclusive U.S. distributor of a Dantrolene Capsules 25 mg, 50 mg and 100 mg. ...

UK Generic Medicines Market Deliver Significant Savings

uk
A new independent report by economics consultancy Oxera has underlined the critical importance of the United Kingdom generic medicines sector and how, via free competition, it provides sustained and s...

Novartis Won Federal Court Order which Block Gilenya Generics Sale in US

Novartis has won a U.S. federal court order preventing rival generic makers from selling versions of the Swiss drugmaker’s top-selling multiple sclerosis medicine Gilenya in the United States, at leas...

Chinese Plan on Generics Production

The list, which includes drugs that treat serious diseases such as AIDS and leukemia, has been published on the commission's website and is soliciting public opinion for five working days. The Nati...

Teva Launch Generic Version of Tracleer in the U.S.

generics
Teva Pharmaceutical Industries Ltd., announced the launch of a generic version of Tracleer® (bosentan) tablets, 62.5 mg and 125 mg, in the U.S. Bosentan Tablets are an endothelin receptor antagonis...

Glenmark Receives FDA Tentative Approval for Mylan Generic

Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted tentative approval by the United States Food & Drug Administration (U.S. FDA) for Clindamycin Phosphate Foam, 1%, a generic version o...

New FDA Effort to Improve Transparency for Generics Applicants

Statement of the Acting Commissioner of Food and Drugs - Food and Drug Administration, Norman E. "Ned" Sharpless MD on a new effort to improve transparency and predictability for generic drug applican...

Teva Announced the Launch of Generic Version of Ranexa® in the U.S.

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Ranexa® (ranolazine) Extended-Release Tablets, 500 mg and 1000 mg, in the U.S. Ranolazine Extended-Release Tablets a...

FDA Published Final REMS Guideline

The U.S. Food and Drug Administration (FDA) affirms its commitment to efficient adoption of Risk Evaluation and Mitigation Strategy (REMS) plans and to making sure they do not impede generic drug deve...

Sandoz to Undergo Workforce Reorganization

Sandoz
Sandoz announces plans for a leaner and more efficient global organization, to drive cost competitiveness as the first stage of its ongoing strategic Transformation and support investments into future...

Sandoz Receives Generic Approval for Rosuvastatin in China

Sandoz
Sandoz today announced that it has received regulatory approval from China's National Medical Products Administration (NMPA) for its generic Rosuvastatin, under the NMPA's Quality Consistency Evaluati...

Teva Launched Generic Version of Tarceva®

Teva Pharmaceutical Industries Ltd. announced the launch of a generic version of Tarceva® (erlotinib) tablets, 100 and 150 mg, in the U.S. Erlotinib Tablets are a kinase inhibitor indicated for the...

Nativa Won Several Legal Disputes over Pfizer

The issuing of a compulsory license for the production of a patent-protected drug in Russia may take place shortly, due to the recent victory of several legal disputes with US pharma giant Pfizer by l...

Oakrum Pharma Agreed With Biophore India to Develop Generics

Oakrum Pharma, LLC has entered an agreement with Biophore India Pharmaceuticals Pvt. Ltd. to develop and manufacture two prescription generic pharmaceuticals for commercialization in the U.S. under th...

Сomparative Outcomes of Generics and Brand-Name Meds

A recent study provides evidence that the use of generic medications for chronic conditions is associated with comparable clinical outcomes to the use of brand-name products. Although generic versi...